$ASTH News

Astrana Health: 81% Full-Risk And Profitable

Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55

Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat

Astrana Health, Inc. 2026 Q2 - Results - Earnings Call Presentation

Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est

Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est

Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate

Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run

2 Reasons to Like ASTH and 1 to Stay Skeptical

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50

BTIG Maintains Buy on Astrana Health, Raises Price Target to $65

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum

Astrana Health (ASTH) Gets Upgraded by Barclays

Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth

BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target